Month: June 2022

Series  RIKV 22 0824 RIKV 22 1019Settlement Date  06/29/2022 06/29/2022Total Amount Allocated (MM)  32,250 2,700All Bids Awarded At (Price / Simple interest)  99.213 / 5.099 98.273 / 5.649Total Number of Bids Received  19 5Total Amount of All Bids Received (MM)  32,550 2,700Total Number of Successful Bids  17 5Number of Bids Allocated in Full  17 5Lowest Price / Highest Simple Interest Allocated  99.213 / 5.099 98.273 / 5.649Highest Price / Lowest Simple Interest Allocated  99.267 / 4.747 98.378 / 5.300Lowest Price / Highest Simple Interest Allocated in Full  99.213 / 5.099 98.273 / 5.649Weighted Average of Successful Bids (Price/Simple Interest)  99.241 / 4.917 98.316 / 5.506Best Bid (Price / Simple Interest)  99.267 / 4.747 98.378 / 5.300Worst Bid (Price / Simple Interest)  99.198 / 5.197 98.273 / 5.649Weighted...

LAS VEGAS, NV, June 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a technology company specializing in Biotech and Numismatics, is pleased to announce that its wholly owned subsidiary Global Stem Cells Group has completed the signing of an exclusive 5-year contract with Ramzan Ali Stem Cell Center to expand the company’s service for patients, doctors and product lines into Pakistan, the world’s 5th most populous healthcare market. “This partnership seeks to expand the Global Stem Cell Group (GSCG) brand by creating centers of excellence in cell therapy to meet the demand in the Asian and Middle Eastern markets,” said David Christensen, CEO of MSSV. “GSCG is rapidly expanding its operations globally as it seeks to be a significant player in the lucrative...

BOCA RATON, Fla., June 27, 2022 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that Chief Executive Officer, Chairman, and Founder, Jim Cacioppo, has purchased 100,000 Class B Subordinate Voting Shares (“Shares”) of the Company in the open market for an approximate amount of $151,000. Mr. Cacioppo holds in the aggregate approximately 16.9% of the issued and outstanding Subordinate Voting Shares (calculated in accordance with National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and on a non-diluted basis). Jim Cacioppo, Chief Executive Officer, Chairman, and Founder of Jushi, stated, “I am confident in our growth strategy and long-term outlook and have increased...

JERSEY CITY, N.J., June 27, 2022 (GLOBE NEWSWIRE) — Fortune magazine and Great Place to Work have honored Verisk (Nasdaq: VRSK) as one of the Best Workplaces in New York for the second consecutive year. The award recognizes Verisk, a leading global data analytics provider, for its outstanding workplace culture of engagement through education and development, team collaboration and open communication. The Best Workplaces in New York award is based on employee feedback collected through America’s largest ongoing annual workforce study of over 1 million employee survey responses and data from companies representing more than 6.1 million U.S. employees. In that survey 83% of Verisk’s employees said Verisk is a great place to work, compared to 57% of employees at the average U.S.-based company. “In today’s rapidly-evolving landscape,...

WILMINGTON, N.C., June 27, 2022 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced that Chris Ainsworth has joined the Company as its first Chief People Officer, serving as a member of the nCino Executive Leadership Team. “At nCino, one of our highest priorities and most valuable assets has and will continue to be our people,” said Pierre Naudé, Chairman and Chief Executive Officer of nCino. “Chris brings to nCino more than two decades of experience and a proven track record of leading high-performing human resources and talent teams in complex global financial organizations. I am confident his knowledge and perspective will enable us to continue attracting, hiring, developing and retaining the best people in...

NEW YORK, June 27, 2022 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced data presentations highlighting data from pooled and post hoc analyses of the ULTIMATE I & II Phase 3 trials evaluating ublituximab in patients with relapsing forms of multiple sclerosis (RMS), presented at the 8th Congress of the European Academy of Neurology (EAN). Links to the presentations are included below. Michael S. Weiss, Chairman and Chief Executive Officer of TG Therapeutics stated, “We are encouraged by the findings from these additional exploratory analyses of the ULTIMATE I & II Phase 3 trials, which reinforces our belief in the potential of ublituximab in the treatment of relapsing forms of multiple sclerosis. As a company, our primary focus remains on obtaining FDA approval of ublituximab by December 28, 2022,...

SUNNYVALE, Calif., June 27, 2022 (GLOBE NEWSWIRE) — Matterport, Inc. (Nasdaq: MTTR), the leading spatial data company driving the digital transformation of the built world, will join the Russell 2000® Index at the conclusion of the 2022 Russell indexes annual reconstitution. The Russell 2000® Index is a subset of the Russell 3000® Index composed of small-cap stocks. The annual reconstitution will be effective after the US market opens on June 27, according to a preliminary list of additions posted June 3. Membership in the Russell 2000 Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. “We are pleased Matterport has been added...

VANCOUVER, British Columbia, June 27, 2022 (GLOBE NEWSWIRE) — Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Dr. Alan Kozikowski will no longer serve in the role of Chief Scientific Officer. “Alan has been with Bright Minds since the beginning, and his leadership was instrumental in shaping our vision and discovery efforts. As Bright Minds advances its first drug candidate BMB-101, we are now transitioning from a discovery to a clinical phase company and look forward to this new stage of growth. On behalf of the entire Company, I would like to thank Alan for his service and dedication,” said Ian McDonald, CEO and Co-founder of...

CAMBRIDGE, Mass., June 27, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from solid tumors, today announced the appointment of Eric Sullivan as Chief Financial Officer where he will be responsible for leading all aspects of financial management and capital market strategy as well as overseeing investor relations and select business operations. “We are excited to announce Eric Sullivan is joining the TCR2 team as Chief Financial Officer,” said Garry Menzel, Ph.D., President and Chief Executive Officer of TCR2 Therapeutics. “Eric brings a tremendous breadth of financial, strategy, operational and leadership experience to the Company having served in multiple roles at high-growth companies during his tenure in the...